The device as well as the production are certified according to the EC guidelines 93/42/EEC Annex II as well as EN ISO 1497:2012, EN ISO 13485:2012 and EN ISO 9001:2008.


papimi is a certified and approved medical device of class IIa.


The American patent was granted on September 17, 1996 (US 5,556,418). The first European patent (EP 0648.140.B1) was granted on January 31, 2001 and the second (EP 04.743.704.1) in August 2003.


Our premium service ensures that your device always performs flawlessly. Our staff will also inform you about our many warranty options.


With the papimi Delta, ion induction therapy (IIT) has arrived in the 21st century. This physical cell therapy sets new standards in medicine. Learn more about the original according to Prof DDr Pappas.

Experts about papimi

papimi Events

No event found!



  • Register Here   Listen to Dr. Hartner and other experts talk about mitochondiral medicine and share their experiences with supporing therapy forms. (Attention: Event is held in German!) Description: Regenerative mitochondrial medicine is a comparatively young form of therapy in the field of human medicine,......

  • After the race is before the race. We are happy about the success and congratulate the women's ski racer, Sofia Goggia (Olympia 2nd ski race). Also for the coming season we wish good luck and health! Get ready to pulse!...

  • Register Now Our special recommendation is Prof. Dr. Thomas Rau’s webinar on Silent Inflammation and Cell Membante Potentials – Explaining Ion-Induction-Therpy (IIT). (Attention: This event is held in German) Dear colleagues, Silent inflammation as a cause of chronic diseases, unnoticed by the patients, often presents......